| Announce Date | 10/22/2025 |
| EPS Normalized Actual | $0.22 (Beat by $0.03) |
| EPS GAAP Actual | $0.22 (Beat by $0.03) |
| Revenue Actual | $0.134521B |
| Revenue Surprise | Beat by $134.521M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.32481 |
| EPS GAAP Estimate | $0.32481 |
| Revenue Estimate | $0.147111236B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 1.48 | 10.17 | 1.42977 | 1.55309 | 0 |
| Dec 2027 | 1.34 | 11.24 | 1.29452 | 1.40618 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.3 | -0.00587 | 0.134521B | 0.09% | -9.24M |
| FQ2 2025 (Jun 2025) | 0.22 | -0.07392 | 0.130159B | -0.32% | -13.35M |
| FQ1 2025 (Mar 2025) | -0.0033 | -0.0033 | 0.123585B | -4.9% | 123.59M |
| FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 0.129237B | 0.79% | 129.24M |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 0.134397B | 6.74% | 134.4M |
| FQ2 2024 (Jun 2024) | 0.19 | 0.19 | 0.130577B | 2.06% | 130.58M |
| FQ1 2024 (Mar 2024) | 0 | 0 | 0.129637B | 0.99% | 129.64M |
| FQ2 2023 (Jun 2023) | 0.48 | 0.48 | 0.127881B | 100% | 127.88M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.32481
Consensus Revenue Estimates
0.147111236B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26446 | -- | 0.25292 | 0.27761 | 1 |
| FQ3 2027 (Sep 2027) | 0.27532 | -- | 0.27058 | 0.27825 | 1 |
| FQ2 2027 (Jun 2027) | 0.26752 | -- | 0.26291 | 0.27037 | 1 |
| FQ1 2027 (Mar 2027) | 0.21913 | -- | 0.20957 | 0.23003 | 1 |
| FQ4 2026 (Oct 2026) | 0.3202 | -- | 0.31059 | 0.33006 | 1 |
| FQ3 2026 (Jul 2026) | 0.295 | -1.69 | 0.28615 | 0.30409 | 1 |
| FQ2 2026 (Jun 2026) | 0.295 | 25.42 | 0.28909 | 0.30031 | 1 |
| FQ1 2026 (Mar 2026) | 0.2635 | 101.25 | 0.25822 | 0.26824 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.13B | -- | 0.13B | 0.14B | 2 |
| FQ3 2027 (Sep 2027) | 0.14B | -- | 0.13B | 0.14B | 2 |
| FQ2 2027 (Jun 2027) | 0.14B | -- | 0.13B | 0.14B | 2 |
| FQ1 2027 (Mar 2027) | 0.13B | -- | 0.12B | 0.13B | 2 |
| FQ4 2026 (Oct 2026) | 0.11B | -- | 0.11B | 0.11B | 2 |
| FQ3 2026 (Jul 2026) | 0.11B | -18.09 | 0.11B | 0.12B | 2 |
| FQ2 2026 (Jun 2026) | 0.45B | 70.99 | 0.44B | 0.45B | 2 |
| FQ1 2026 (Mar 2026) | 0.42B | 70.34 | 0.41B | 0.42B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.30587 | 0.3 | -0.00587 | -1.96% |
| FQ2 2025 (Jun 2025) | 0.29392 | 0.22 | -0.07392 | -33.6% |
| FQ1 2025 (Mar 2025) | -0.0033 | -0.0033 | 100% | |
| FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 100% | |
| FQ3 2024 (Sep 2024) | 0.25 | 0.25 | 100% | |
| FQ2 2024 (Jun 2024) | 0.19 | 0.19 | 100% | |
| FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
| FQ2 2023 (Jun 2023) | 0.48 | 0.48 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.14B | $0.13B | $-9.24M | -6.87% |
| FQ2 2025 (Jun 2025) | $0.14B | $0.13B | $-13.35M | -10.26% |
| FQ1 2025 (Mar 2025) | $0B | $0.12B | $123.59M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.13B | $129.24M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.13B | $134.4M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.13B | $130.58M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.13B | $129.64M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $0.13B | $127.88M | 100% |